Asset Allocation

As of October 31, 2025.
Type % Net
Cash 3.67%
Stock 55.30%
Bond 39.81%
Convertible 0.00%
Preferred 0.00%
Other 1.23%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 55.63%
Mid 25.14%
Small 19.24%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 97.12%    % Emerging Markets: 0.32%    % Unidentified Markets: 2.56%

Americas 91.59%
89.57%
Canada 0.71%
United States 88.86%
2.02%
Mexico 0.29%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.78%
United Kingdom 0.72%
5.03%
France 0.18%
Germany 0.14%
Ireland 3.13%
Italy 0.02%
Netherlands 1.05%
Spain 0.04%
Switzerland 0.41%
0.02%
Poland 0.02%
0.00%
Greater Asia 0.06%
Japan 0.05%
0.00%
0.02%
Singapore 0.02%
0.00%
Unidentified Region 2.56%

Bond Credit Quality Exposure

AAA 12.03%
AA 20.41%
A 7.15%
BBB 8.69%
BB 16.96%
B 11.04%
Below B 0.60%
    CCC 0.60%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 23.12%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
42.83%
Materials
2.72%
Consumer Discretionary
6.75%
Financials
11.89%
Real Estate
21.47%
Sensitive
35.69%
Communication Services
3.41%
Energy
3.40%
Industrials
6.52%
Information Technology
22.37%
Defensive
21.47%
Consumer Staples
4.74%
Health Care
10.21%
Utilities
6.52%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 0.74%
Corporate 47.95%
Securitized 51.17%
Municipal 0.00%
Other 0.14%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.89%
Less than 1 Year
1.89%
Intermediate
43.47%
1 to 3 Years
7.59%
3 to 5 Years
13.98%
5 to 10 Years
21.90%
Long Term
54.64%
10 to 20 Years
9.15%
20 to 30 Years
28.46%
Over 30 Years
17.03%
Other
0.00%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial